Patents by Inventor Jeffrey Shimizu

Jeffrey Shimizu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11938295
    Abstract: Ingestible devices can directly deliver therapeutic agents to desired tissue(s) of the GI tract of a subject, such as the submucosa, the mucosa, and/or the mucus layer of the GI tract, and methods of using the same. The ingestible devices can deliver therapeutic agents in a safe, effective, and reliable manner. The disclosure also provides pharmaceutical compositions for use in methods of treating a disease or condition in a subject in need thereof.
    Type: Grant
    Filed: September 15, 2022
    Date of Patent: March 26, 2024
    Assignee: Biora Therapeutics, Inc.
    Inventors: Jeffrey A. Shimizu, Mitchell Lawrence Jones, Mark Sasha Drlik, Iman Niknia, Nathan John Muller, Tuyen Nguyen, Christopher Loren Wahl, Edward Mudge, Nicholas Mark Salt, Nia Eleri Stevens, Stuart Robert Abercrombie, Christopher Ian Bunce, Ryan Elliott Jones, Kevin Howe, Pejman Rahimian, Nelson Quintana
  • Patent number: 11707610
    Abstract: Ingestible devices can directly deliver therapeutic agents to desired tissue(s) of the GI tract of a subject, such as the submucosa, the mucosa, and/or the mucus layer of the GI tract, and methods of using the same. The ingestible devices can deliver therapeutic agents in a safe, effective, and reliable manner. The disclosure also provides pharmaceutical compositions for use in methods of treating a disease or condition in a subject in need thereof.
    Type: Grant
    Filed: December 11, 2020
    Date of Patent: July 25, 2023
    Assignee: BIORA THERAPEUTICS, INC.
    Inventors: Jeffrey A. Shimizu, Mitchell Lawrence Jones, Mark Sasha Drlik, Iman Niknia, Nathan John Muller, Tuyen Nguyen, Christopher Loren Wahl, Edward Mudge, Nicholas Mark Salt, Nia Eleri Stevens, Stuart Robert Abercrombie, Christopher Ian Bunce, Ryan Elliott Jones, Kevin Howe, Pejman Rahimian, Nelson Quintana
  • Publication number: 20230149315
    Abstract: Ingestible devices can directly deliver therapeutic agents to desired tissue(s) of the GI tract of a subject, such as the submucosa, the mucosa, and/or the mucus layer of the GI tract, and methods of using the same. The ingestible devices can deliver therapeutic agents in a safe, effective, and reliable manner. The disclosure also provides pharmaceutical compositions for use in methods of treating a disease or condition in a subject in need thereof.
    Type: Application
    Filed: December 11, 2020
    Publication date: May 18, 2023
    Inventors: Jeffrey A. SHIMIZU, Mitchell Lawrence JONES, Mark Sasha DRLIK, Iman NIKNIA, Nathan John MULLER, Tuyen NGUYEN, Christopher Loren WAHL, Edward MUDGE, Nicholas Mark SALT, Nia Eleri STEVENS, Stuart Robert ABERCROMBIE, Christopher Ian BUNCE, Ryan Elliott JONES, Kevin David HOWE, Pejman RAHIMIAN, Nelson QUINTANA
  • Publication number: 20230023414
    Abstract: This disclosure features methods and devices for treating diseases with orally-delivered biotherapeutics.
    Type: Application
    Filed: November 19, 2019
    Publication date: January 26, 2023
    Inventors: Jeffrey A. Shimizu, Mitchell Lawrence Jones, Mark Sasha Drlik, Iman Niknia, Nathan John Muller, Tuyen Nguyen, Christopher Loren Wahl, Edward Mudge, Nicholas Mark Salt, Nia Eleri Stevens, Stuart Robert Abercrombie, Christopher Ian Bunce, Nelson Quintana
  • Publication number: 20230017603
    Abstract: Ingestible devices can directly deliver therapeutic agents to desired tissue(s) of the GI tract of a subject, such as the submucosa, the mucosa, and/or the mucus layer of the GI tract, and methods of using the same. The ingestible devices can deliver therapeutic agents in a safe, effective, and reliable manner. The disclosure also provides pharmaceutical compositions for use in methods of treating a disease or condition in a subject in need thereof.
    Type: Application
    Filed: September 15, 2022
    Publication date: January 19, 2023
    Inventors: Jeffrey A. SHIMIZU, Mitchell Lawrence JONES, Mark Sasha DRLIK, Iman NIKNIA, Nathan John MULLER, Tuyen NGUYEN, Christopher Loren WAHL, Edward MUDGE, Nicholas Mark SALT, Nia Eleri STEVENS, Stuart Robert ABERCROMBIE, Christopher Ian BUNCE, Ryan Elliott JONES, Kevin HOWE, Pejman RAHIMIAN, Nelson QUINTANA
  • Patent number: 11439802
    Abstract: A method of treating a disease or condition in a subject in need thereof is disclosed. The method comprising: trans-epithelially administering a dispensable substance to the gastrointestinal (GI) tract of the subject by orally administering an ingestible device comprising the dispensable substance to the subject. The ingestible device is configured for trans-epithelial delivery of the dispensable substance to the GI tract of the subject and the dispensable substance comprises a pharmaceutical formulation comprising a therapeutically effective amount of a glucagon receptor agonist or a glucagon-like peptide-1 (GLP-1) receptor agonist. The ingestible device releases the dispensable substance as at least one jet to a desired location of the GI tract of the subject.
    Type: Grant
    Filed: May 13, 2021
    Date of Patent: September 13, 2022
    Assignee: Biora Therapeutics, Inc.
    Inventors: Jeffrey A. Shimizu, Mitchell Lawrence Jones, Mark Sasha Drlik, Iman Niknia, Nathan John Muller, Tuyen Nguyen, Christopher Loren Wahl, Edward Mudge, Nicholas Mark Salt, Nia Eleri Stevens, Stuart Robert Abercrombie, Christopher Ian Bunce, Nelson Quintana
  • Publication number: 20220249814
    Abstract: This disclosure features methods and devices for treating diseases with orally-delivered biotherapeutics.
    Type: Application
    Filed: November 19, 2019
    Publication date: August 11, 2022
    Inventors: Jeffrey A. Shimizu, Mitchell Lawrence Jones, Mark Sasha Drlik, Iman Niknia, Nathan John Muller, Tuyen Nguyen, Christopher Loren Wahl, Edward Mudge, Nicholas Mark Salt, Nia Eleri Stevens, Stuart Robert Abercrombie, Christopher Ian Bunce, Nelson Quintana
  • Patent number: 11241562
    Abstract: Ingestible devices with a relatively large payload volume or sample volume, as well as related components, systems and methods, are disclosed.
    Type: Grant
    Filed: March 12, 2019
    Date of Patent: February 8, 2022
    Assignee: Progenity, Inc.
    Inventors: Mitchell Lawrence Jones, Russell B. Ford, Edward G. Solomon, Jeffrey A. Shimizu
  • Publication number: 20210299419
    Abstract: Ingestible devices with a relatively large payload volume or sample volume, as well as related components, systems and methods, are disclosed.
    Type: Application
    Filed: June 14, 2021
    Publication date: September 30, 2021
    Inventors: Mitchell Lawrence Jones, Russell B. Ford, Edward G. Solomon, Jeffrey A. Shimizu
  • Publication number: 20210283385
    Abstract: An ingestible device, includes a storage reservoir configured to store a dispensable substance and a pressurized chamber configured so that, when a restraining force is removed from the pressurized chamber, the dispensable substance exits the ingestible device via openings in the ingestible device.
    Type: Application
    Filed: May 13, 2021
    Publication date: September 16, 2021
    Inventors: Jeffrey A. Shimizu, Mitchell Lawrence Jones, Mark Sasha Drlik, Iman Niknia, Nathan John Muller, Tuyen Nguyen, Christopher Loren Wahl, Edward Mudge, Nicholas Mark Salt, Nia Eleri Stevens, Stuart Robert Abercrombie, Christopher Ian Bunce, Nelson Quintana
  • Publication number: 20210161805
    Abstract: A capsule includes a compressible reservoir and a gas generating unit disposed in a housing. A threshold valve seals an opening in the housing, through which contents of the reservoir may exit the capsule. Gas generated by the gas generating unit increases pressure in the capsule, thereby compressing the reservoir. When a pressure acting on the threshold valve reaches a threshold pressure, the threshold valve opens, releasing contents of the reservoir.
    Type: Application
    Filed: February 8, 2021
    Publication date: June 3, 2021
    Inventors: Hans Zou, Jeffrey A. Shimizu, Ventzeslav Petrov Iordanov, Klaas Kerkhof, Christoph Wanke
  • Patent number: 11007356
    Abstract: An ingestible device, includes a storage reservoir configured to store a dispensable substance and a pressurized chamber configured so that, when a restraining force is removed from the pressurized chamber, the dispensable substance exits the ingestible device via openings in the ingestible device.
    Type: Grant
    Filed: September 17, 2020
    Date of Patent: May 18, 2021
    Assignee: Progenity, Inc.
    Inventors: Jeffrey A. Shimizu, Mitchell Lawrence Jones, Mark Sasha Drlik, Iman Niknia, Nathan John Muller, Tuyen Nguyen, Christopher Loren Wahl, Edward Mudge, Nicholas Mark Salt, Nia Eleri Stevens, Stuart Robert Abercrombie, Christopher Ian Bunce, Nelson Quintana
  • Publication number: 20210038872
    Abstract: An ingestible device, includes a storage reservoir configured to store a dispensable substance and a pressurized chamber configured so that, when a restraining force is removed from the pressurized chamber, the dispensable substance exits the ingestible device via openings in the ingestible device.
    Type: Application
    Filed: September 17, 2020
    Publication date: February 11, 2021
    Inventors: Jeffrey A. Shimizu, Mitchell Lawrence Jones, Mark Sasha Drlik, Iman Niknia, Nathan John Muller, Tuyen Nguyen, Christopher Loren Wahl, Edward Mudge, Nicholas Mark Salt, Nia Eleri Stevens, Stuart Robert Abercrombie, Christopher Ian Bunce, Nelson Quintana
  • Publication number: 20190374207
    Abstract: An ingestible device includes a sample chamber configured to hold a sample, the sample chamber including a base having an aperture; a fluorometer separated from the sample chamber by the sample chamber base, the fluorometer including (I) a light source configured to emit excitation light, (II) a light guide configured to guide the excitation light from the light source to the sample, (III) a photodetector configured to detect emission light generated via the interaction of the excitation light with the sample. The photodetector is configured to receive the emission light from the sample through the aperture. Additionally, the fluorometer includes (IV) an emission filter between the aperture and the photodetector, the emission filter configured to (i) transmit the emission light incident thereon, and (ii) block excitation light incident thereon. In addition, the ingestible device includes a housing that houses the sample chamber and the fluorometer.
    Type: Application
    Filed: June 6, 2019
    Publication date: December 12, 2019
    Inventors: Mitchell Lawrence Jones, Todd Louis Harris, John Paul Bowen, Aaron Olafur Laurence Philippsen, Jeffrey A. Shimizu, Sharat Singh
  • Publication number: 20190282791
    Abstract: Ingestible devices with a relatively large payload volume or sample volume, as well as related components, systems and methods, are disclosed.
    Type: Application
    Filed: March 12, 2019
    Publication date: September 19, 2019
    Inventors: Mitchell Lawrence Jones, Russell B. Ford, Edward G. Solomon, Jeffrey A. Shimizu
  • Publication number: 20190223846
    Abstract: In some implementations of this disclosure, a fluid sampling device includes an outer housing formed as a capsule, i.e., configured for swallowing by a patient, such as a mammalian patient. In such implementations, the fluid sampling device may be configured to sample fluids in the GI tract.
    Type: Application
    Filed: September 12, 2017
    Publication date: July 25, 2019
    Inventors: Klaas Kerkhof, Ventzeslav Petrov Iordanov, Jeffrey A. Shimizu
  • Publication number: 20190046721
    Abstract: In some implementations, a fluid delivery device includes a compressible dispensing chamber defining a dispensing volume and including a dispensing chamber inlet in fluid communication with a reservoir and a dispensing chamber outlet in fluid communication with an environment. A first one-way valve at the reservoir outlet or the dispensing chamber inlet selectively allows flow of the substance from the reservoir to the compressible dispensing chamber and a second one-way valve at the dispensing chamber outlet selectively allows flow of the substance from the dispensing chamber to the environment. An actuator selectively compresses the compressible dispensing chamber to decrease the dispensing volume and expel the substance in the dispensing chamber through the dispensing chamber outlet.
    Type: Application
    Filed: February 24, 2017
    Publication date: February 14, 2019
    Inventors: Ventzeslav Petrov lordanov, Blagoy P. Iliev, Klaas Kerkhof, Jeffrey A. Shimizu, Robert Fienieg, Jacob Brinkert, Ronald F. A. Tonnie te Vruchte - Haj Modiri
  • Publication number: 20180271752
    Abstract: A system for administering a medicament includes a plurality of capsules, a capsule dispenser, and a capsule activator. Each of the capsules includes a reservoir containing a medicament and an outlet in communication with the reservoir through which the medicament exits the capsule. The capsule dispenser releasably contains the ingestible capsules and is adapted to dispense the capsules to a user in accordance with a predetermined schedule. The capsule activator activates the dispensed capsules prior to administration to the user.
    Type: Application
    Filed: February 2, 2018
    Publication date: September 27, 2018
    Inventors: Ventzeslav Petrov Iordanov, Hans Zou, Christoph Wanke, Klaas Kerkhof, Jeffrey A. Shimizu
  • Patent number: 9918904
    Abstract: A system for administering a medicament includes a plurality of capsules, a capsule dispenser, and a capsule activator. Each of the capsules includes a reservoir containing a medicament and an outlet in communication with the reservoir through which the medicament exits the capsule. The capsule dispenser releasably contains the ingestible capsules and is adapted to dispense the capsules to a user in accordance with a predetermined schedule. The capsule activator activates the dispensed capsules prior to administration to the user.
    Type: Grant
    Filed: September 23, 2013
    Date of Patent: March 20, 2018
    Assignee: Stoco 10 GmbH
    Inventors: Ventzeslav Petrov Iordanov, Hans Zou, Christoph Wanke, Klaas Kerkhop, Jeffrey A. Shimizu
  • Publication number: 20160235663
    Abstract: A capsule includes a compressible reservoir and a gas generating unit disposed in a housing. A threshold valve seals an opening in the housing, through which contents of the reservoir may exit the capsule. Gas generated by the gas generating unit increases pressure in the capsule, thereby compressing the reservoir. When a pressure acting on the threshold valve reaches a threshold pressure, the threshold valve opens, releasing contents of the reservoir.
    Type: Application
    Filed: September 25, 2014
    Publication date: August 18, 2016
    Inventors: Hans Zou, Jeffrey A. Shimizu, Ventzeslav Petrov Iordanov, Klaas Kerkhof, Christoph Wanke